Feasibility and Safety of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy With or Without Intraoperative Intravenous 5-Fluorouracil and Leucovorin for Colorectal Peritoneal Metastases: A Multicenter Comparative Cohort Study

Autor: Abdelkader Taibi, Olivia Sgarbura, Martin Hübner, Sylvia M. Bardet, Mohammed Alyami, Naoual Bakrin, Sylvaine Durand Fontanier, Clarisse Eveno, Johan Gagniere, Basile Pache, Marc Pocard, François Quenet, Hugo Teixeira Farinha, Emilie Thibaudeau, Frederic Dumont, Olivier Glehen

Publikováno v: Annals of surgical oncology, vol. 29, no. 8, pp. 5243-5251

This retrospective multicenter cohort study compared the feasibility and safety of oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-Ox) with or without intraoperative intravenous 5-fluorouracil (5-FU) and leucovorin (L). Our

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e5d9d5a7d6beb5812f690049def0d8d
https://doi.org/10.1245/s10434-022-11577-2

Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases A Phase 2 Randomized Clinical Trial

Autor: Arjen J. Witkamp, Joost Nederend, Andreas J A Bremers, Philip R. de Reuver, Wilhelmina M U van Grevenstein, Henk M.W. Verheul, Koen P. Rovers, Max J. Lahaye, Niels F. M. Kok, Jurriaan B. Tuynman, Checca Bakkers, Maartje Los, Ignace H. J. T. de Hingh, Anna M.J. Thijs, Patrick H. J. Hemmer, Alexandra R. M. Brandt-Kerkhof, Miriam Koopman, Onno Kranenburg, Petur Snaebjornsson, Marcel G. W. Dijkgraaf, Simon W. Nienhuijs, Arend G. J. Aalbers, Schelto Kruijff, Jacobus W. A. Burger, Tineke E. Buffart, Derk Jan A. de Groot, Esther van Meerten, Iris van 't Erve, Geert-Jan Creemers, Miranda Kusters, Pieter J. Tanis, Eva V. E. Madsen, Remond J.A. Fijneman, Kathelijn S. Versteeg, Djamila Boerma, Cornelis J A Punt, Marinus J. Wiezer

Publikováno v: Rovers, K P, Bakkers, C, Nienhuijs, S W, Burger, J W A, Creemers, G-J M, Thijs, A M J, Brandt-Kerkhof, A R M, Madsen, E V E, van Meerten, E, Tuynman, J B, Kusters, M, Versteeg, K S, Aalbers, A G J, Kok, N F M, Buffart, T E, Wiezer, M J, Boerma, D, Los, M, de Reuver, P R, Bremers, A J A, Verheul, H M W, Kruijff, S, de Groot, D J A, Witkamp, A J, van Grevenstein, W M U, Koopman, M, Nederend, J, Lahaye, M J, Kranenburg, O, Fijneman, R J A, van 't Erve, I, Snaebjornsson, P, Hemmer, P H J, Dijkgraaf, M G W, Punt, C J A, Tanis, P J & de Hingh, I H J T 2021, ' Perioperative systemic therapy vs cytoreductive surgery and hyperthermic intraperitoneal chemotherapy alone for resectable colorectal peritoneal metastases: A phase 2 randomized clinical trial ', JAMA Surgery, vol. 156, no. 8, pp. 710-720 . https://doi.org/10.1001/jamasurg.2021.1642
JAMA Surgery, 156(8), 710-720. American Medical Association
JAMA surgery, 156(8), 710-720. American Medical Association
JAMA Surgery, 156(8), 710-720. AMER MEDICAL ASSOC
JAMA Surgery, 156, 710-720
JAMA Surg
JAMA Surgery, 156, 8, pp. 710-720

Contains fulltext : 238268.pdf (Publisher’s version ) (Closed access) IMPORTANCE: To date, no randomized clinical trials have investigated perioperative systemic therapy relative to cytoreductive surgery and hyperthermic intraperitoneal chemotherap

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::375b682e7bd1c0c6ebfa96df3e48e33e
https://hdl.handle.net/11370/c9e531bb-9f62-460d-afc2-636baf20eec6

Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy

Autor: Jesper Nors, Lene Hjerrild Iversen, Karsten Nielsen, Mette Møller Sørensen, Victor Jilbert Verwaal, Jonas Amstrup Funder

Publikováno v: Nors, J B, Iversen, L H, Nielsen, K, Sørensen, M M, Verwaal, V & Funder, J A 2022, ' Peritoneal metastases found in routinely resected specimens after cytoreductive surgery and heated intraperitoneal chemotherapy ', European Journal of Surgical Oncology, vol. 48, no. 4, pp. 795-802 . https://doi.org/10.1016/j.ejso.2021.12.026

Introduction: Peritoneal metastases (PM) originating from colorectal cancer (CRC) and pseudomyxoma peritonei (PMP) can be treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Certain sites in the peritoneal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e8d079905148cb55f0a592bbdec14cb
https://pubmed.ncbi.nlm.nih.gov/35012833

The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI)

Autor: Koen P. Rovers, Victor J. Verwaal, Melissa Ching Ching Teo, Paul H. Sugarbaker, Santiago González-Moreno, Yan Li, M. Bushati, John Spiliotis, Kuno Lehmann, S.P. Somashekhar, I.H.J.T. de Hingh, David L. Morris, B. J. Moran, Pierre Dubé, M. Deraco, Claudio Almeida Quadros, Pompiliu Piso, Y. Yonemura, Peter H Cashin, Antonio Sommariva, Olivier Glehen, Wim Ceelen

Publikováno v: Bushati, M, Rovers, K P, Sommariva, A, Sugarbaker, P H, Morris, D L, Yonemura, Y, Quadros, C A, Somashekhar, S P, Ceelen, W, Dubé, P, Li, Y, Verwaal, V J, Glehen, O, Piso, P, Spiliotis, J, Teo, M C C, González-Moreno, S, Cashin, P H, Lehmann, K, Deraco, M, Moran, B & de Hingh, I H J T 2018, ' The current practice of cytoreductive surgery and HIPEC for colorectal peritoneal metastases: Results of a worldwide web-based survey of the Peritoneal Surface Oncology Group International (PSOGI) ', European Journal of Surgical Oncology, vol. 44, no. 12, pp. 1942-1948 . https://doi.org/10.1016/j.ejso.2018.07.003

Background: At present, selected patients with resectable colorectal peritoneal metastases (CRC-PM) are increasingly treated with a combination therapy of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a82bb1b771b84e288adc004ad776718
https://doi.org/10.1016/j.ejso.2018.07.003

Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indications

Autor: Alyami, M., Hübner, M., Grass, F., Bakrin, N., Villeneuve, L., Laplace, N., Passot, G., Glehen, O., Kepenekian, V.

Publikováno v: The Lancet. Oncology, vol. 20, no. 7, pp. e368-e377

Pressurised intraperitoneal aerosol chemotherapy (PIPAC) was introduced as a new treatment for patients with peritoneal metastases in November, 2011. Reports of its feasibility, tolerance, and efficacy have encouraged centres worldwide to adopt PIPAC

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::7bab09ce3ba4663b6588b09bbaa3ec64
https://serval.unil.ch/resource/serval:BIB_8AFF34473ED9.P001/REF.pdf